- Home
- NUWE vs HAS Comparison
NUWE vs HAS Comparison
Compare NUWE & HAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUWE
- HAS
- Stock Information
- Founded
- NUWE 1999
- HAS 1923
- Country
- NUWE United States
- HAS United States
- Employees
- NUWE N/A
- HAS N/A
- Industry
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- HAS Recreational Games/Products/Toys
- Sector
- NUWE Health Care
- HAS Consumer Discretionary
- Exchange
- NUWE Nasdaq
- HAS Nasdaq
- Market Cap
- NUWE 3.9M
- HAS N/A
- IPO Year
- NUWE N/A
- HAS N/A
- Fundamental
- Price
- NUWE $1.00
- HAS $61.57
- Analyst Decision
- NUWE Strong Buy
- HAS Strong Buy
- Analyst Count
- NUWE 1
- HAS 9
- Target Price
- NUWE $17.00
- HAS $79.56
- AVG Volume (30 Days)
- NUWE 70.5K
- HAS 2.6M
- Earning Date
- NUWE 05-13-2025
- HAS 04-24-2025
- Dividend Yield
- NUWE N/A
- HAS 4.51%
- EPS Growth
- NUWE N/A
- HAS N/A
- EPS
- NUWE N/A
- HAS 3.03
- Revenue
- NUWE $8,740,000.00
- HAS $4,265,300,000.00
- Revenue This Year
- NUWE $22.96
- HAS $1.54
- Revenue Next Year
- NUWE $29.97
- HAS $5.17
- P/E Ratio
- NUWE N/A
- HAS $20.48
- Revenue Growth
- NUWE N/A
- HAS N/A
- 52 Week Low
- NUWE $0.75
- HAS $49.00
- 52 Week High
- NUWE $12.60
- HAS $73.46
- Technical
- Relative Strength Index (RSI)
- NUWE 52.93
- HAS 61.34
- Support Level
- NUWE $0.87
- HAS $50.55
- Resistance Level
- NUWE $1.06
- HAS $62.64
- Average True Range (ATR)
- NUWE 0.09
- HAS 2.60
- MACD
- NUWE 0.02
- HAS 1.32
- Stochastic Oscillator
- NUWE 79.31
- HAS 92.16
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.